Westwood Holdings Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,904
| Closed | -$586K | – | 563 |
|
|
2022
Q3 | $586K | Sell |
6,904
-5,832
| -46% | -$495K | 0.01% | 357 |
|
|
2022
Q2 | $1.06M | Sell |
12,736
-76
| -0.6% | -$6.3K | 0.01% | 339 |
|
|
2022
Q1 | $988K | Sell |
12,812
-1,474
| -10% | -$114K | 0.01% | 358 |
|
|
2021
Q4 | $1.26M | Buy |
14,286
+5,906
| +70% | +$522K | 0.01% | 333 |
|
|
2021
Q3 | $648K | Sell |
8,380
-673
| -7% | -$52K | 0.01% | 365 |
|
|
2021
Q2 | $755K | Sell |
9,053
-3,938
| -30% | -$328K | 0.01% | 362 |
|
|
2021
Q1 | $981K | Sell |
12,991
-1,604
| -11% | -$121K | 0.01% | 344 |
|
|
2020
Q4 | $1.28M | Sell |
14,595
-656
| -4% | -$57.5K | 0.01% | 319 |
|
|
2020
Q3 | $1.16M | Sell |
15,251
-907
| -6% | -$69K | 0.01% | 307 |
|
|
2020
Q2 | $1.99M | Buy |
16,158
+1,943
| +14% | +$240K | 0.03% | 285 |
|
|
2020
Q1 | $1.2M | Sell |
14,215
-1,858
| -12% | -$157K | 0.02% | 301 |
|
|
2019
Q4 | $1.36M | Sell |
16,073
-200
| -1% | -$16.9K | 0.01% | 331 |
|
|
2019
Q3 | $1.1M | Sell |
16,273
-564
| -3% | -$38K | 0.01% | 331 |
|
|
2019
Q2 | $1.44M | Sell |
16,837
-2,027
| -11% | -$174K | 0.02% | 329 |
|
|
2019
Q1 | $1.68M | Sell |
18,864
-189
| -1% | -$16.8K | 0.02% | 284 |
|
|
2018
Q4 | $1.62M | Sell |
19,053
-437
| -2% | -$37.2K | 0.02% | 267 |
|
|
2018
Q3 | $1.89M | Sell |
19,490
-4,053
| -17% | -$393K | 0.02% | 273 |
|
|
2018
Q2 | $2.22M | Buy |
23,543
+6,323
| +37% | +$596K | 0.02% | 279 |
|
|
2018
Q1 | $1.4M | Buy |
+17,220
| New | +$1.4M | 0.01% | 306 |
|